1. Whole-exome sequencing: opportunities in pediatric endocrinology
- Author
-
Caroline Hasselmann, Mark E. Samuels, Guy Van Vliet, Cheri Deal, and Johnny Deladoëy
- Subjects
Pharmacology ,Sanger sequencing ,symbols.namesake ,Pediatric endocrinology ,Research context ,symbols ,Molecular Medicine ,General Medicine ,Biology ,Bioinformatics ,Genome ,Exome sequencing ,DNA sequencing - Abstract
Pediatric endocrinology services see a wide variety of patients with diverse clinical symptoms, including disorders of growth, metabolism, bone and sexual development. Molecular diagnosis plays an important role in this branch of medicine. Traditional PCR-based Sanger sequencing is a mainstay format for molecular testing in pediatric cases despite its relatively high cost, but the large number of gene defects associated with the various endocrine disorders renders gene-by-gene testing increasingly unattractive. Using new high-throughput sequencing technologies, whole genomes, whole exomes or candidate-gene panels (targeted gene sequencing) can now be cost-effectively sequenced for endocrine patients. Based on our own recent experiences with exome sequencing in a research context, we describe the general clinical ascertainment of relevant pediatric endocrine patients, compare different formats for next-generation sequencing and provide examples. Our view is that protocols involving next-generation sequencing should now be considered as an appropriate component of routine clinical diagnosis for relevant patients.
- Published
- 2014
- Full Text
- View/download PDF